Strainprint™ Technologies Ltd is proud to continue its expansion into the prosperous U.S. cannabis market with the addition of DocMJ to its repertoire of clients. DocMJ is a medical practice based out of Florida devoted to helping potential medical cannabis patients determine whether they are eligible to receive medical cannabis, and if so, they connect them with qualified physicians throughout the state.
“Strainprint is providing us with invaluable tools that will ultimately optimize our treatment guidance for our patients. Their data and analytics will not only help us make more informed decisions about what to recommend, and also what trends are on the horizon,” said Derek Hundley COO of DocMJ. “We’ll be able to streamline the often tedious process of figuring out which strain is best suited for which symptom or condition, and recommend products that best align with our patients situational variables.”
DocMJ will have access to Strainprint’s full technology suite, starting with a DocMJ-custom-branded version of the Strainprint mobile app (The White Label App) for its medical cannabis patients. The app is free to patients, allowing them to track their treatment sessions in real-time and understand how to achieve the best results for their symptoms. The custom-branded version of the app includes loyalty tools that drive engagement through redeemable discounts on merchandise.
DocMJ will also have premium access with the Enterprise Clinical Strainprint Analytics web platform, enabling them to learn from more than 1.4 million anonymized, crowd-sourced medical outcomes and more than 70 million data points on strain efficacy, making it the largest and most granular scientific data set of its kind in the world. The data from Strainprint Analytics will allow DocMJ to follow their patients’ performance in real-time and ultimately lead to better treatment guidance.
Doctors/Educators will be able to see their patient’s cannabis use.
“Recommending cannabis medicine can be complicated, so we jump at the opportunity to partner with organizations who are trying to simplify that process. We admire DocMJ’s commitment to providing affordable and direct access to medical cannabis recommendations across the state of Florida,” said Strainprint CEO, Andrew Muroff. “We anticipate that our highly intuitive, real-time data and analytics will provide their patients with superior treatment guidance and a highly efficient and convenient user experience.”
For more information, visit www.strainprintanalytics.com and www.docmj.com.